-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom
These three sleeper stocks could deliver massive gains if their cutting-edge technologies take off in the coming years.
Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success
The challenge for Alnylam now will be to find and diagnose patients with the condition known as ATTR-CM, which is considered rare.
Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts
Ginkgo Bioworks layoffs are a hot topic as the company prepares to cut 158 jobs this week with more headcount reductions coming next week.
Why Is G1 Therapeutics (GTHX) Stock Down 56% Today?
G1 Therapeutics stock is down on Monday as GTHX investors react to the company's Phase 3 clinical trial of trilaciclib failing.
Why Is DermTech (DMTK) Stock Down 26% Today?
DermTech stock is down on Monday as investors prepare for shares of DMTK to be delisted from the Nasdaq Exchange later this week.
Why Is Agrify (AGFY) Stock Up 70% Today?
Agrify stock is up on Monday alongside heavy pre-market trading of AGFY shares despite a lack of news from the cannabis support company.
7 A-Rated Penny Stocks to Beat June Gloom
Some penny stocks can be diamonds in the rough. These A-rated penny stocks are all solid picks for a portfolio this month.
7 Top Stocks Under $10: June 2024 Edition
While blue chip stocks are great, it's also a good idea to invest in top stocks under $10 to help improve your portfolio's diversification.
The 3 Healthiest Healthcare Stocks to Buy for a Huge Dose of Profits
Explore three top growth-ready healthcare stocks to buy amid rising demand for healthcare services globally.
3 REITs to Sell in June Before They Crash & Burn
Various REITs are at risk of performing poorly, despite possessing alluring face value metrics. Consider avoiding ONL, FPI and MPW.
3 Biotech Stocks to Buy Now: June 2024
These are the three best biotech stocks to buy for long-term returns and portfolio stability due to their target patient populations,
7 Cannabis Stocks to Buy Now: June 2024
Cannabis may be controversial. But it’s also proving to be one of the most profitable, with some of the top cannabis stocks to buy now.
3 Hypergrowth Stocks That You Want to Be Early On
Hypergrowth stocks to buy don't always have to be high risk as this list proves since many profitable, stable firms also grow rapidly.
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
How much Sarepta can hope to earn from Elevidys is unclear due to its cost, $3 million, and that it's not a cure. Yet SRPT stock is surging.
3 Undiscovered Stocks to Buy Before Their Big Breakout Rally
These are the undiscovered stocks to buy as they represent undervalued ideas with a healthy revenue and EBITDA growth outlook
Defying the Norms: 3 High P/E Stocks With Room to Run
Gilead Sciences, Crowdstrike and DataDog might be the best high P/E stocks to buy, offering substantial growth despite elevated valuations.
7 F-Rated Penny Stocks to Avoid This June
There are risks associated with any investment – there’s no such thing as a surefire investment, although tools like the Portfolio Grader can make your…
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for June 2024
Enjoy the endorsements of these strong buy healthcare stocks.